Patents Assigned to Jiangsu Genscript Probio Biotech Co., Ltd.
  • HEK293 CELL LINE ADAPTED TO SERUM-FREE SUSPENSION CULTURE AND USE THEREOF
    Publication number: 20240425880
    Abstract: A HEK293 cell line adapted to serum-free suspension culture and a use thereof. Specifically, the present application relates to a method for preparing a viral vector such as an adeno-associated virus vector using the cell line, and a method for screening the cell line.
    Type: Application
    Filed: October 12, 2022
    Publication date: December 26, 2024
    Applicant: JIANGSU GENSCRIPT PROBIO BIOTECH CO., LTD.
    Inventors: Yan WANG, Xiao PAN, Rongna DING, Erjing HUI, Chunling XUAN
  • HEK293T CELL STRAIN HAVING HIGH DISPERSIBILITY AND SCREENING METHOD THEREFOR
    Publication number: 20240101964
    Abstract: Provided are a HEK293T cell strain having high dispersibility and a screening method therefor. Specifically, the present application relates to a method for screening a HEK293T cell strain suitable for serum-free suspension culture, a cell strain screened by using the method, and a method for producing a viral vector by using the cell strain.
    Type: Application
    Filed: December 28, 2021
    Publication date: March 28, 2024
    Applicant: Jiangsu Genscript Probio Biotech Co., Ltd.
    Inventors: Chen Guo, Shenghua Xie, Chunling Xuan, Erjing Hui, Rongna Ding